Membership required to view content. provides market intelligence for global cannabis markets. As with our reporting in hemp, cannabis markets are underpinned by significant policy issues that have outsized influence on markets. At the Prohibition Partners Conference this week, medical professionals discussed issues relevant to cannabinoid therapies in their areas of specialty, and in their jurisdictions. Our reporting on the Hemp Products and Animal Health Conference this week addressed parallel issues in veterinary medicine.
All segments of industry and science are innovating in the pan-cannabis space it seems and researchers are especially drawn to the vast opportunities for unique discovery. Cannabis is increasingly accessible to researchers, but for some, remains inaccessible. Until this week, The University of Mississippi had a virtual monopoly on MJ research for the last half century.
…
Membership is required to view the rest of this post.
Click here to learn more and sign up for a free 7-day trial!